The Global H1N1 Vaccines Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing include increasing incidence of various diseases, increasing investments in research & development, and increasing medical infrastructure.
Based on vaccine type the market is categorized into attenuated vaccines, inactivated vaccine, intranasal, conjugate, intramuscular, and toxoid. On basis of disease type the market is segmented by influenza, hepatitis, mumps, meningococcal, pneumococcal, rubella, cervical cancer, measles, and other disease types.
Depending on the type of brand devices the market is segregated into nasovac, fiuarix, agripal, vaxigrip, influgen, influvac, and other brands.
This industry report analyzes the global markets for H1N1 (Swine Influenza) across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
The H1N1 (Swine Influenza) Market report provides data tables, includes charts and graphs for visual analysis.
Regional Analysis: North America - US - Canada - Mexico
Europe - France - Germany - Italy - Spain - UK - Rest of Europe
Asia Pacific - China - Japan - India - Australia - New Zealand - Rest of Asia
Middle East - Saudi Arabia - UAE - Rest of Middle East
Latin America - Argentina - Brazil - Rest of Latin America
Rest of the World -Africa -Caribbean
Report Highlights: - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments
Our reports have been used by over 10K customers, including:
Executive Summary The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are...
This study ’s Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants.
Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Drugs In Development, 2021 Summary According to the recently published report ’Neuropeptide Y Receptor Type 2 - Drugs In Development, 2021’; Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) pipeline Target constitutes close to 5...
The Middle East and Africa multiple sclerosis therapeutics market is expected to reach US$ 2,027.86 million by 2027 from US$ 1,319.08 million in 2019; it is estimated to grow at a CAGR of 5.7% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increasing awareness about multiple sclerosis amongst...
The global neoantigens market is expected to reach US$ 10,54,783.54 thousand by 2028 from US$ 2,71,428.57 thousand in 2020. It is estimated to grow at a CAGR of 18.49% during 2020-2028. Cancer has emerged as a leading cause of death worldwide.According to the World Health Organization (WHO), cancer was the first leading cause of death...
120 pages •
By Infiniti Research Limited
• May 2021
Global Microbiomes Market 2021-2025 The analyst has been monitoring the microbiomes market and it is poised to grow by $ 713.01 million during 2021-2025, progressing at a CAGR of over 24% during the forecast period. Our report on microbiomes market provides a holistic analysis, market size and forecast, trends, growth drivers,...
205 pages •
By Global Industry Analysts
• May 2021
Global Digital Therapeutics Market to Reach US$1.6 Billion by the Year 2027
Amid the COVID-19 crisis, the global market for Digital Therapeutics estimated at US$347.2 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 24.6%...
Acute Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 Summary Acute Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Acute Lymphoblastic Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under...
Chronic Cough (Respiratory) - Drugs in Development, 2021 Summary Chronic Cough (Respiratory) - Drugs in Development, 2021 provides an overview of the Chronic Cough pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Cough, complete...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.